kabutan

TORII PHARMA, First Half Ordinary Profit Increases by 16%

Thu Jul 31, 2025 3:30 pm JST Earnings

4551 TORII PHARMACEUTICAL CO., LTD. 【J-GAAP】

Earnings Report

TORII PHARMACEUTICAL CO., LTD. <4551> [TSE Prime] announced its financial results after the market closed on July 31st (15:30). The ordinary profit (non-consolidated) for the cumulative second quarter of the fiscal year ending December 2025 (January to June) increased 16.2% from the same period last year, reaching 3.46 billion yen. Progress toward the full-year plan of 4.50 billion yen was 77.1%, also surpassing the five-year average of 42.7%.

In the most recent three-month period, from April to June (2Q), the ordinary profit decreased to 1.60 billion yen, an 11.5% decrease compared to the same period last year. The operating profit margin decreased from 11.8% in the same period last year to 8.7%.

Kabutan News

Actual Results

Accumulated Results 2nd Quarter
Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Progress Rate vs. First Half Announce Accounting Standards
Jan - Jun, 2023 25,699 1,510 1,543 1,086 38.7 29.1 Jul 31, 2023 J-GAAP
Jan - Jun, 2024 28,309 3,141 2,985 2,221 79.0 43.1 Jul 31, 2024 J-GAAP
Jan - Jun, 2025 31,379 3,152 3,468 2,588 92.1 77.1 Jul 31, 2025 J-GAAP
YoY +10.8% +0.4% +16.2% +16.5% +16.5%

First Half Results vs. Previous Guidance

Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Adj. Dividend Announce Accounting Standards
Jan - Jun, 2025 Guidance ー ー ー ー － 0 May 7, 2025 J-GAAP
Jan - Jun, 2025 Results 31,379 3,152 3,468 2,588 92.1 0 Jul 31, 2025 J-GAAP
Revision Rate － － － － －

Current Period Guidance

Second Half Results

Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Adj. Dividend Announce Accounting Standards
Jul - Dec, 2024 32,117 3,657 3,941 2,821 100.4 60 Feb 7, 2025 J-GAAP
Jul - Dec, 2025 Guidance 33,321 948 1,032 812 28.9 0 Jul 31, 2025 J-GAAP
YoY +3.7% -74.1% -73.8% -71.2% -71.2%

Current Period Guidance

Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Adj. Dividend Announce Accounting Standards
Dec, 2023 54,638 5,035 5,307 4,119 146.6 120 Feb 9, 2024 J-GAAP
Dec, 2024 60,426 6,798 6,926 5,042 179.4 120 Feb 7, 2025 J-GAAP
Dec, 2025 Guidance 64,700 4,100 4,500 3,400 120.9 0 May 7, 2025 J-GAAP
YoY +7.1% -39.7% -35.0% -32.6% -32.6%

Quarterly Results

Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Operating Profit Margin Announce Accounting Standards
Apr - Jun, 2024 14,858 1,758 1,819 1,343 47.8 11.8 Jul 31, 2024 J-GAAP
Jul - Sep, 2024 15,024 1,520 1,701 1,304 46.4 10.1 Oct 31, 2024 J-GAAP
Oct - Dec, 2024 17,093 2,137 2,240 1,517 54.0 12.5 Feb 7, 2025 J-GAAP
Jan - Mar, 2025 14,683 1,704 1,859 1,391 49.5 11.6 Apr 25, 2025 J-GAAP
Apr - Jun, 2025 16,696 1,448 1,609 1,197 42.6 8.7 Jul 31, 2025 J-GAAP
YoY +12.4% -17.6% -11.5% -10.9% -10.9%

Related Articles